The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 5, 2013, Pages 804-808

  Patil, Sangita M ^a   Banker, M P ^b   Padalkar, Ramchandra K ^c   Pathak, Abhijit P ^a   Bhagat, Sonali S ^a   Ghone, Rahul ^a   Phatake, Anjali S ^a  

^a PDVVPF's College of Pharmacy   (India)

^b Clinical Trials Unit   (India)

^c Cardiologist   (India)

Author keywords

Acute coronary syndrome; Ischaemia modified albumin

Indexed keywords

BIOLOGICAL MARKER; COBALT; ISCHEMIA MODIFIED ALBUMIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BINDING ASSAY; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

EID: 84877108184     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5288.2944     Document Type: Article

References (22)

1. Eftihia S, Panagiota G, Dimitrios T, Kremastinos, Vasilious V. Ischemia modified Albumin: This marker of ischemia ready for prime time use?. Hellenic J Cardiol. 2008; 49:260-66.
2. Vamadevan S, Ajay, Doraraj P. Prevalence. Indian J. Med. Res. 2010; 132:561-66.
3. Plebani M. Biochemical markers of cardiac damage: from efficiency to effectiveness. Clin Clim. Acta. 2001; 311:3-7.
4. Chawla R, Navendu G, Rajneesh C, Shweta Goyal. Ischemia Modified Albumin: A novel marker for acute coronary syndrome. Indian Journal of Clinical Biochemistry. 2006; 21 (1):77-82.
5. Kritsanee M, Titiporn M, Saowanee L, Tomon T, Sarawut K. Combinational determination of ischemia modified albumin and protein carbonyl in the diagnosis of non ST-elevation Myocardial Infarction. Indian Journal of Clinical Biochemistry. 2011; 26 (4):389-95.
6. ShaoquingJu, Juan NI, Jianyou SU, Min PAN, Jianhua Z. Ischemia modified albumin is increased in patients with unstable angina: a new potential diagnostic biomarker of this acute coronary syndrome? Science. 2008; 39 (11):668-70.
7. Bhagwan N, Ernest M, Rios P, Yang J, et al., Evolution of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin.Chem. 2003; 49:581-85.
8. Bar-Or D, Lau E, Winker J. A novel assay for cobalt-albumin binding and it,s potential as a marker formyocardial ischemia-a preliminary report. J Emerg Med. 2000; 19:311-15.
9. Fluroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clinical Chemistry. 1996; 42 (9): 1460-66.
10. Takshid M, Kojuri, Tabei B, Tavasouli A, Heidary S, Tabanbeh M. Early Diagnosis of acute coronary syndrome with Sensitive Troponin I and Ischemia Modified Albumin. Iranian Cardiovascular Research Journal. 2010; 4 (4): 144-51.
11. Sinha MK, Roy D, Gaze D, Collinson P, Kaski J. Role of IMA a new biochemical marker of myocardial Ischemia in the early diagnosis of acute coronary syndrome. Emerg. Med. J. 2004; 21: 29-34.
12. Nayak A, Rajpal K, Dinesh K, Purohit H, Taori G, Daginawala H. Prognostic Significance of Ischemia Modified Albumin in acute Ischemic stroke patients: A preliminary study. Annals of Neurosciences. 2011; 18 (1):5-7.
13. Eftihia S, Panagiota G, Vassilis V. Ischemia modified albumin as an acute-phase reactant. European Journal of Cardiovascular Medicine. 2011;1 (3):81-83.
14. Peacock F, Morris D, Anwaruddin S, Christenson R, Collinson P, Goodware S. Meta-analysis of Ischemia Modified Albumin to rule out acute coronary syndromes in the emergency department. Am Heart J. 2006; 152:253-262.
15. Cui L, Zhang J, Wu Yonghua, Hu Xiaozhou. Assay of ischemia-modified albumin and C-reactive protein bfor early diagnosis of acute coronary syndromes. Journal of Clinical Laboratory Analysis. 2008; 22: 45-49.
16. Dominguez RA, Abreu G, Garcia G,Samini F, Reiter R, Kaski J. Asso-ciation of ischemia modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis. 2008;199:73-78.
17. Mothes E, Faller P. Evidence that the principal coII binding site in human serum albumin is not at the N terminus: implication on the albumincobalt binding test for detecting myocardial ischemia. Biochemistry. 2007; 46:2267-2274.
18. Garrido I, Roy D, Calvino R, et al. comparison of ischemia modified albumin levels in patients undergoging percytaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol. 2004; 93:88-90.
19. Till K, Tanja Z, Dirk P, Ewa C. et al. Sensitive Troponin I assay in early diagnosis of acute myocardial infarction. The New England Journal of Medicine. 2009; 361 (9):868-877.
20. Carlos A, David R, Catherine J, Douglas P, Philip K, Harold H. Cardaic-specific Troponin I levels risk of coronary artery disease and graft failure following heart transplantation. JAMA. 2000;284:457-64.
21. Saif A, James LJ, Aaron LB, Elizabeth LL, Kent BL. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol. 2005;123:140-45.
22. Collinson P, Gaze D, Bainbridge K, et al. Utility of admission cardiac Troponin and Ischemia modified albumin measurements for rapid evalution and rule out of suspwcted acute myocardial infarction in the emergency department. Emerg Med J. 2006;23:256-61